Price Alert: Shares of Accelerate Diagnostics (AXDX) Trade 21.67% Higher at Midday August 5

Equities Staff  |

Shares of Accelerate Diagnostics Inc (NASDAQ: AXDX) rose 21.67% Friday.

As of 11:46:51 est, Accelerate Diagnostics sits at $2.18 and has risen $0.39 so far today.

Accelerate Diagnostics has moved 93.07% over the last 30 days and has moved YTD 62.64% based on the prior day’s close.

The company expects its next earnings on 2022-08-15.

For technical charts, analysis, and more on Accelerate Diagnostics visit the company profile.

About Accelerate Diagnostics Inc

Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno® system and Accelerate PhenoTest® BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for deadly infections. The FDA cleared system and kit fully automate the sample preparation steps to report phenotypic antibiotic susceptibility results in approximately 7 hours direct from positive blood cultures. Recent external studies indicate the solution offers results 1-2 days faster than existing methods, enabling clinicians to optimize antibiotic selection and dosage specific to the individual patient days earlier.

To get more information on Accelerate Diagnostics Inc and to follow the company's latest updates, you can visit the company's profile page here: Accelerate Diagnostics Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

These Stocks are Sending a Signal (like Amazon in 2008)
It Isn’t a Recession Until This Group of Economists Says So
What You Should Know About Europe's Energy Wars
Meatless Meats and Smokeless Smokes
Mixed Wireless Recovery at AT&T, Verizon, T-Mobile: Jeff Kagan



Market Movers

Sponsored Financial Content